Heng Lin
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- Peroxisome Proliferator-Activated Receptors 11
- Immunology 30
- interferon and immune responses 14
- Immune Response and Inflammation 11
- Co-authors
- Ching‐Feng Cheng (30 shared papers)Hui‐Chen Ku (4 shared papers)Hong‐Bing Shu (14 shared papers)Ming‐Ming Hu (9 shared papers)Fang Hua (14 shared papers)Hsi-Hsien Chen (20 shared papers)Zhi Chen (13 shared papers)Hsiao‐Fen Li (12 shared papers)
- Journals
- Journal of Cellular Physiology (6 papers)Molecular Pharmacology (6 papers)Scientific Reports (4 papers)International Journal of Molecular Sciences (4 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Heng Lin
132 papers receiving 5.3k citations
Heng Lin's Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 920
- Immunology 1.2k
- Molecular Biology 2.9k
- Nephrology 224
- Epidemiology 1.1k
Countries citing papers authored by Heng Lin
This map shows the geographic impact of Heng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Lin more than expected).
Fields of papers citing papers by Heng Lin
This network shows the impact of papers produced by Heng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Lin. The network helps show where Heng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Heng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation Hit paper breakdown → | 2018 | 338 |
| 2 | 2016 | 305 | |
| 3 | 2012 | 141 | |
| 4 | 2014 | 135 | |
| 5 | 2019 | 134 | |
| 6 | 2014 | 120 | |
| 7 | 2015 | 115 | |
| 8 | 2005 | 115 | |
| 9 | 2012 | 112 | |
| 10 | 2011 | 112 | |
| 11 | 2017 | 96 | |
| 12 | 2019 | 91 | |
| 13 | 2013 | 89 | |
| 14 | 2006 | 89 | |
| 15 | 2019 | 85 | |
| 16 | 2010 | 84 | |
| 17 | 2011 | 80 | |
| 18 | 2012 | 80 | |
| 19 | 2020 | 78 | |
| 20 | 2015 | 77 |
About Heng Lin
Heng Lin is a scholar working on Molecular Biology, Immunology, Epidemiology, Cancer Research and Physiology, having authored 135 papers that have together received 5.4k indexed citations. Recurring topics across this work include interferon and immune responses (14 papers), Autophagy in Disease and Therapy (12 papers), MicroRNA in disease regulation (12 papers), Peroxisome Proliferator-Activated Receptors (11 papers), Immune Response and Inflammation (11 papers), Adipose Tissue and Metabolism (10 papers), NF-κB Signaling Pathways (9 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (920 citations), Immunology (1.2k citations), Molecular Biology (2.9k citations), Nephrology (224 citations) and Epidemiology (1.1k citations). Heng Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ching‐Feng Cheng, Hui‐Chen Ku, Hong‐Bing Shu, Ming‐Ming Hu, Fang Hua, Hsi-Hsien Chen, Zhi Chen, Hsiao‐Fen Li, Huan Liu and Pei‐Fang Lai. Their work appears in journals such as Journal of Cellular Physiology, Molecular Pharmacology, Scientific Reports, International Journal of Molecular Sciences and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.